Literature DB >> 25560245

Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells.

Ting Chan1, Ling Zhu, Michele C Madigan, Ke Wang, Weiyong Shen, Mark C Gillies, Fanfan Zhou.   

Abstract

BACKGROUND AND
PURPOSE: Vision depends on retinoid exchange between the retinal pigment epithelium (RPE) and photoreceptors. Defects in any step of the canonical visual cycle can lead to retinal degenerations. All-trans-retinol (atROL) plays an important role in visual signal transduction. However, how atROL enters human RPE from the apical membrane remains unclear. This study investigated the role of human organic anion transporting polypeptide 1A2 (OATP1A2) in atROL uptake in human RPE. EXPERIMENTAL APPROACH: Immunoblotting and immunostaining elucidated the expression and localization of OATP1A2 in human RPE. Transporter functional studies were conducted to assess the interaction of OATP1A2 with atROL. KEY
RESULTS: Our study revealed OATP1A2 is expressed in human RPE, mainly at the apical membrane. Our data also indicated atROL inhibited the uptake of the typical OATP1A2 substrate, oestrone-3-sulfate (E3S), in over-expressing cells. Studies on the uptake of (3) H-atROL in these over-expressing cells revealed atROL is a substrate of OATP1A2. We confirmed these findings in human primary RPE cells. The transport of E3S and atROL was significantly reduced in human primary RPE cells with OATP1A2 siRNA silencing. CONCLUSION AND IMPLICATIONS: Our data provides the first evidence of OATP1A2 expression in human RPE and more importantly, its novel role in the cellular uptake of atROL, which might be essential to the proper functioning of the canonical visual cycle. Our findings contribute to the understanding of the molecular mechanisms involved in retinoid transport between the RPE and photoreceptors and provide novel insights into potential pharmaceutical interventions for visual cycle disruption associated with retinal degenerations.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25560245      PMCID: PMC4403098          DOI: 10.1111/bph.13060

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.

Authors:  Tao Zhang; Cathie D Xiang; David Gale; Samantha Carreiro; Ellen Y Wu; Eric Y Zhang
Journal:  Drug Metab Dispos       Date:  2008-04-14       Impact factor: 3.922

2.  Separation of phenotypically distinct subpopulations of cultured human retinal pigment epithelial cells.

Authors:  B S McKay; J M Burke
Journal:  Exp Cell Res       Date:  1994-07       Impact factor: 3.905

3.  A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy.

Authors:  R Allikmets
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

4.  Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS.

Authors:  Bo Gao; Stephan R Vavricka; Peter J Meier; Bruno Stieger
Journal:  Pflugers Arch       Date:  2014-08-19       Impact factor: 3.657

Review 5.  Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes.

Authors:  Emmanuelle Reboul; Patrick Borel
Journal:  Prog Lipid Res       Date:  2011-07-08       Impact factor: 16.195

Review 6.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

7.  Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry.

Authors:  Wooin Lee; Hartmut Glaeser; L Harris Smith; Richard L Roberts; Gilbert W Moeckel; Guillermo Gervasini; Brenda F Leake; Richard B Kim
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

8.  Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants.

Authors:  Ilaria Badagnani; Richard A Castro; Travis R Taylor; Claire M Brett; Conrad C Huang; Douglas Stryke; Michiko Kawamoto; Susan J Johns; Thomas E Ferrin; Elaine J Carlson; Esteban G Burchard; Kathleen M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2006-05-15       Impact factor: 4.030

9.  Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye.

Authors:  Aki Ito; Katsuhiro Yamaguchi; Hiroshi Tomita; Takehiro Suzuki; Tohru Onogawa; Takeaki Sato; Hiroya Mizutamari; Tsuyoshi Mikkaichi; Toshiyuki Nishio; Takashi Suzuki; Michiaki Unno; Hironobu Sasano; Takaaki Abe; Makoto Tamai
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  7 in total

Review 1.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 2.  Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.

Authors:  Wooin Lee; Jeong-Min Ha; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

Review 3.  Roles of Drug Transporters in Blood-Retinal Barrier.

Authors:  Li Liu; Xiaodong Liu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  Transporters in the Mammary Gland-Contribution to Presence of Nutrients and Drugs into Milk.

Authors:  Alba M García-Lino; Indira Álvarez-Fernández; Esther Blanco-Paniagua; Gracia Merino; Ana I Álvarez
Journal:  Nutrients       Date:  2019-10-05       Impact factor: 5.717

Review 5.  Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease.

Authors:  Alejandra Daruich; Emilie Picard; Jeffrey H Boatright; Francine Behar-Cohen
Journal:  Mol Vis       Date:  2019-10-14       Impact factor: 2.367

Review 6.  Hydroxychloroquine in rheumatic autoimmune disorders and beyond.

Authors:  Eliise Laura Nirk; Fulvio Reggiori; Mario Mauthe
Journal:  EMBO Mol Med       Date:  2020-07-26       Impact factor: 12.137

Review 7.  Interphotoreceptor Retinoid-Binding Protein (IRBP) in Retinal Health and Disease.

Authors:  Shaoxue Zeng; Ting Zhang; Michele C Madigan; Nilisha Fernando; Riemke Aggio-Bruce; Fanfan Zhou; Matthew Pierce; Yingying Chen; Lianlin Huang; Riccardo Natoli; Mark C Gillies; Ling Zhu
Journal:  Front Cell Neurosci       Date:  2020-11-19       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.